HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahito Shimizu Selected Research

clobenpropit

1/2017Erratum: Tanaka, T. et al. Cimetidine and Clobenpropit Attenuate Inflammation-Associated Colorectal Carcinogenesis in Male ICR Mice. Cancers, 2016, 8, 25.
2/2016Cimetidine and Clobenpropit Attenuate Inflammation-Associated Colorectal Carcinogenesis in Male ICR Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahito Shimizu Research Topics

Disease

76Neoplasms (Cancer)
05/2022 - 03/2004
59Carcinogenesis
12/2021 - 06/2003
46Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2004
35Inflammation (Inflammations)
01/2022 - 05/2008
27Obesity
09/2020 - 09/2008
22Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 09/2007
21Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 01/2009
20Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2005
17Fibrosis (Cirrhosis)
05/2022 - 11/2008
17Colonic Neoplasms (Colon Cancer)
12/2020 - 01/2005
14Body Weight (Weight, Body)
02/2017 - 05/2008
13Lymphoma (Lymphomas)
08/2019 - 06/2006
12Insulin Resistance
01/2019 - 05/2009
10Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2020 - 06/2006
10Liver Neoplasms (Liver Cancer)
09/2020 - 09/2007
9Liver Diseases (Liver Disease)
05/2022 - 09/2007
9Malnutrition (Nutritional Deficiencies)
03/2022 - 01/2012
8Sarcopenia
01/2022 - 12/2017
8Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2020 - 06/2002
7Hemorrhage
05/2022 - 04/2016
7Adenoma (Adenomas)
01/2022 - 10/2007
7Non-alcoholic Fatty Liver Disease
12/2021 - 01/2013
7Fatty Liver
07/2021 - 01/2011
7Infections
04/2021 - 12/2016
7Neoplasm Metastasis (Metastasis)
08/2019 - 09/2015
6Alcoholic Fatty Liver
07/2021 - 12/2015
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2019 - 01/2010
6Aberrant Crypt Foci
12/2014 - 09/2008
5Adenocarcinoma
12/2021 - 06/2003
5Colitis
12/2021 - 05/2008
5Breast Neoplasms (Breast Cancer)
01/2016 - 02/2004
4Fistula
07/2022 - 01/2016
4Muscle Cramp (Cramp)
01/2022 - 01/2020
4Hepatic Encephalopathy
01/2022 - 03/2017
4Liver Failure
12/2021 - 01/2012
4Diabetes Mellitus
10/2021 - 09/2008
4Hyperlipidemias (Hyperlipidemia)
03/2018 - 07/2010
4Hyperinsulinism (Hyperinsulinemia)
03/2016 - 05/2009
3Neutropenia
02/2022 - 11/2018

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2003
23TeaIBA
09/2018 - 01/2005
203,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
01/2018 - 02/2004
13AzoxymethaneIBA
12/2021 - 05/2008
13Red Fluorescent ProteinIBA
06/2021 - 09/2015
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 06/2002
12Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2022 - 02/2010
12Pharmaceutical PreparationsIBA
08/2021 - 01/2009
12Branched-Chain Amino AcidsIBA
04/2020 - 11/2008
12RetinoidsIBA
09/2017 - 03/2004
11Retinoid X Receptors (Retinoid X Receptor)IBA
01/2022 - 03/2007
11Prednisolone (Predate)FDA LinkGeneric
01/2020 - 06/2002
11Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 06/2002
11AdipokinesIBA
03/2018 - 07/2010
10Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021 - 04/2011
10Drinking WaterIBA
03/2020 - 05/2008
10Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 04/2011
10epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2016 - 04/2005
10Phosphotransferases (Kinase)IBA
03/2015 - 06/2008
9Rituximab (Mabthera)FDA Link
02/2022 - 04/2011
9Green Fluorescent ProteinsIBA
10/2018 - 01/2016
8Antiviral Agents (Antivirals)IBA
01/2022 - 09/2007
8Messenger RNA (mRNA)IBA
03/2016 - 01/2011
7Serum AlbuminIBA
03/2022 - 02/2013
7CateninsIBA
01/2022 - 06/2011
7Dextrans (Dextran)FDA Link
12/2021 - 05/2008
7sodium sulfate (sodium bisulfate)FDA LinkGeneric
12/2021 - 05/2008
7Insulin (Novolin)FDA Link
03/2020 - 09/2005
7Insulin-Like PeptidesIBA
03/2020 - 04/2008
7tyrosine receptor (receptor, tyrosine)IBA
03/2015 - 06/2008
7ErbB Receptors (EGF Receptor)IBA
07/2011 - 02/2004
6Hemoglobins (Hemoglobin)IBA
11/2021 - 01/2018
6folfirinoxIBA
06/2021 - 12/2017
6CarcinogensIBA
05/2021 - 06/2003
6Interleukin-6 (Interleukin 6)IBA
01/2021 - 03/2010
5BilirubinIBA
05/2022 - 03/2018
5Carnitine (L-Carnitine)FDA LinkGeneric
01/2022 - 03/2017
5AmmoniaIBA
01/2022 - 03/2017
5GemcitabineFDA Link
07/2021 - 01/2009
5Tryptophan (L-Tryptophan)FDA Link
04/2020 - 09/2012
5KynurenineIBA
12/2017 - 09/2015
5beta CateninIBA
07/2010 - 06/2003
4Biomarkers (Surrogate Marker)IBA
05/2021 - 11/2011
4Sorafenib (BAY 43-9006)FDA Link
04/2021 - 04/2015
4pirarubicinIBA
10/2018 - 02/2012
4LipidsIBA
03/2016 - 10/2008
4Biological ProductsIBA
03/2016 - 03/2009
4Catechin (Z 7300)IBA
01/2016 - 04/2005
4EnzymesIBA
01/2016 - 09/2012
4CytokinesIBA
08/2014 - 03/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 03/2010
4IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2012 - 04/2008
4Epidermal Growth Factor (EGF)IBA
07/2011 - 04/2005
4Retinoid X Receptor alphaIBA
11/2009 - 10/2007

Therapy/Procedure

43Chemoprevention
12/2021 - 03/2004
33Therapeutics
02/2022 - 06/2002
22Drug Therapy (Chemotherapy)
03/2022 - 06/2002
8Subcutaneous Injections
09/2017 - 07/2010
5Intraperitoneal Injections
01/2016 - 05/2008
4Stents
01/2022 - 05/2017
4Cell Transplantation
12/2017 - 11/2015